Neo-Oxy 100/100 MR: Product Information
NEO-OXY 100/100 MR- oxytetracycline hydrochloride and neomycin sulfate powder
Pharmgate Animal Health
Neomycin
Oxytetracycline
Type A Medicated Article
CAUTION: Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
Active Drug Ingredients:
Oxytetracycline Hydrochloride 100 grams/lb.
Neomycin Sulfate 100 grams/lb.
For Use in the Manufacture of Medicated Feeds
CAUTION: For Use in Dry Feeds ONLY.
NOT FOR USE IN LIQUID FEED SUPPLEMENTS
Mixing and Use Directions | ||
Mix Neo-Oxy 100/100 MR® with non-medicated milk replacer to provide the following concentrations: | ||
INDICATIONS FOR USE | Use Level of Oxytetracycline and Neomycin | lbs. of Neo-Oxy 100/100 MR per ton of Type C Medicated Feed * |
Calves (milk replacer) | ||
For Calves (up to 250 lb): For treatment of bacterial enteritis caused by Escherichia coli susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible by neomycin. Feed continuously for 7-14 days in milk replacer or starter feed. Treatment should continue 24 to 48 hours beyond remission of disease symptoms. | 10 mg/lb body weight/day | 20† |
RESIDUE WARNING: A WITHDRAWAL PERIOD HAS NOT BEEN ESTABLISHED FOR USE IN PRERUMINATING CALVES. DO NOT USE IN CALVES TO BE PROCESSED FOR VEAL. A MILK DISCARD TIME HAS NOT BEEN ESTABLISHED FOR USE IN LACTATING DAIRY CATTLE. DO NOT USE IN FEMALE DAIRY CATTLE 20 MONTHS OR OLDER, INCLUDING DRY DAIRY COWS. USE IN THESE CATTLE MAY CAUSE DRUG RESIDUES IN MILK AND/OR IN CALVES BORN TO THESE COWS. WITHDRAW 5 DAYS BEFORE SLAUGHTER. USE OF MORE THAN ONE PRODUCT CONTAINING NEOMYCIN OR FAILURE TO FOLLOW WITHDRAWAL TIMES MAY RESULT IN ILLEGAL DRUG RESIDUES | ||
Calves, Beef Cattle, and Nonlactating Dairy Cattle | ||
For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia (shipping fever complex) caused by Pasteurella multocida susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible by neomycin. Feed continuously for 7-14 days in feed or milk replacers. Treatment should continue 24 to 48 hours beyond remission of disease symptoms. | 10 mg/lb body weight/day | 20† |
RESIDUE WARNINGS: A WITHDRAWAL PERIOD HAS NOT BEEN ESTABLISHED FOR USE IN PRERUMINATING CALVES. DO NOT USE IN CALVES TO BE PROCESSED FOR VEAL. A MILK DISCARD TIME HAS NOT BEEN ESTABLISHED FOR USE IN LACTATING DAIRY CATTLE. DO NOT USE IN FEMALE DAIRY CATTLE 20 MONTHS OR OLDER, INCLUDING DRY DAIRY COWS. USE IN THESE CATTLE MAY CAUSE DRUG RESIDUES IN MILK AND/OR IN CALVES BORN TO THESE COWS. WITHDRAW 5 DAYS BEFORE SLAUGHTER. USE OF MORE THAN ONE PRODUCT CONTAINING NEOMYCIN OR FAILURE TO FOLLOW WITHDRAWAL TIMES MAY RESULT IN ILLEGAL DRUG RESIDUES | ||
Store at or below 25°C (77°F) with excursions permitted to 37°C (98.6°F). Approved by FDA under NADA # 138-939 |
Restricted Drug (California)
Use Only as Directed.
Not For Human Use.
Net Weight 50 lbs (22.7 kg)
Marketed by:
Pharmgate Animal Health, LLC
14040 Industrial Road
Omaha, NE 68144
Take TimeObserve Directions
PRINCIPAL DISPLAY PANEL — 22.7 kg Drum Label
Neo-Oxy 100/100 MR®
Neomycin
Oxytetracycline
Type A Medicated Article
CAUTION: Federal law restricts medicated feed
containing this veterinary feed directive (VFD) drug to
use by or on the order of a licensed veterinarian.
NEO-OXY 100/100 MR oxytetracycline hydrochloride and neomycin sulfate powder | |||||||||||||
| |||||||||||||
| |||||||||||||
| |||||||||||||
|
Labeler — Pharmgate Animal Health (833270817) |
Registrant — Pharmgate Inc. (079628671) |
Revised: 10/2023 Pharmgate Animal Health
VetLabel.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by VetLabel.com. Every individual animal healthcare product label entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.